Composition of Australian influenza vaccine for the 2002 season.
ثبت نشده
چکیده
In order to select virus strains for the manufacture of Influenza Vaccine for 2002 Season, a meeting of the Australian Influenza Vaccine Committee (AIVC) on Influenza Vaccines was convened on 11 October 2001. Having considered the information on international surveillance by WHO and up-to-date epidemiology and strain characterisation presented at the meeting, the Committee considered that the WHO recommendations on the composition of vaccines for 2002 Southern Hemisphere Season should be followed: H1N1 strain: an A/New Caledonia/20/99 15 µg HA per dose. (H1N1)-like strain A/New Caledonia/20/99 (IVR-116) is recommended as a suitable vaccine strain. H3N2 strain: an A/Moscow/10/99 (H3N2) 15 µg HA per dose.-like strain A/Panama/2007/99 (RESVIR-17) is recommended as a suitable vaccine strain. B Strain: A B/Sichuan/379/99-like strain 15 µg HA per dose. B/Johannesburg/5/99, B/Victoria/504/00 or B/Guangdong/120/2000 are recommended as the suitable vaccine strain. The SRID reagents for testing the potency of influenza vaccines for A/New Caledonia/20/99 (IVR-116) and A/Panama/2007/99 (RESVIR-17) are available from NIBSC and CBER/FDA.
منابع مشابه
Heterogeneous influenza activity across Europe during the winter of 2002-2003.
Influenza activity varied across Europe during the 2002-2003 season both in terms of the intensity of clinical activity and the circulating virus types/subtypes. Influenza B was generally predominant in the 'western' parts of Europe (Portugal, Spain, the United Kingdom and Ireland) and influenza A (H3N2) in the 'central' and 'eastern' areas (Germany, Italy, Denmark, Switzerland, Poland, Sloveni...
متن کاملImpact of quadrivalent influenza vaccine on public health and influenza-related costs in Australia
BACKGROUND Annual trivalent influenza vaccines (TIV) containing three influenza strains (A/H1N1, A/H3N2, and one B) have been recommended for the prevention of influenza. However, worldwide co-circulation of two distinct B lineages (Victoria and Yamagata) and difficulties in predicting which lineage will predominate each season have led to the development of quadrivalent influenza vaccines (QIV...
متن کاملRecommended composition of influenza virus vaccines for use in the 2018 southern hemisphere influenza season.
The World Health Organization (WHO) convenes technical consultations in February/March and September each year to recommend viruses for inclusion in influenza vaccines for the northern and southern hemisphere influenza seasons, respectively. This recommendation relates to the influenza vaccines for use in the forthcoming southern hemisphere 2018 influenza season. A recommendation will be made i...
متن کاملFrom the Centers for Disease Control. Update: influenza activity--United States, 2001-02 season.
Although influenza activity in the United States remained low from October through mid-January, the number and percentage of specimens testing positive for influenza viruses have increased in recent weeks. Laboratory-confirmed influenza infections have been reported from 45 states. The predominant influenza viruses isolated this season have been type A (H3N2) viruses that are well matched by th...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Communicable diseases intelligence quarterly report
دوره 26 1 شماره
صفحات -
تاریخ انتشار 2002